CAS: 96865-83-7 - [4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy]acetic acid
Fórmula:C19H22N4O5
InChI:InChI=1/C19H22N4O5/c1-3-9-22-17-15(18(26)23(10-4-2)19(22)27)20-16(21-17)12-5-7-13(8-6-12)28-11-14(24)25/h5-8H,3-4,9-11H2,1-2H3,(H,20,21)(H,24,25)
- Sinónimos:
- [4-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)phenoxy]acetic acid
- acetic acid, 2-[4-(2,3,6,9-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
2-[4-(2,3,6,7-Tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-aceticacid REF: IN-DA01ENONCAS: 96865-83-7 | 97% | A consultar | Lun 13 Ene 25 | |
XCC REF: TR-X745160CAS: 96865-83-7 | - - - | 3.559,00 € | Vie 21 Feb 25 | |
XCC REF: TM-T23537CAS: 96865-83-7 | 98% | 1.000,00 €~2.617,00 € | Lun 03 Mar 25 |
2-[4-(2,3,6,7-Tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-aceticacid
CAS:96865-83-7
Fórmula:
C19H22N4O5
Pureza:
97%
Peso molecular:
386.4018
Ref: IN-DA01ENON
5mg | 155,00 € | ||
10mg | 261,00 € | ||
25mg | 490,00 € | ||
50mg | A consultar | ||
100mg | A consultar | ||
250mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 13 de Enero de 2025
XCC
CAS:96865-83-7
XCC is an Adenosine receptor antagonist.
Fórmula:
C19H22N4O5
Pureza:
98%
Forma y color:
Solid
Peso molecular:
386.4
Ref: TM-T23537
50mg | 1.764,00 € |
Entrega estimada en Estados Unidos, el Lunes 3 de Marzo de 2025